Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

CASSETTE-clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation: study protocol for a randomised controlled trial.

Dotel R, Tong SYC, Bowen A, Nelson JN, O'Sullivan MVN, Campbell AJ, McMullan BJ, Britton PN, Francis JR, Eisen DP, Robinson O, Manning L, Davis JS.

Trials. 2019 Jun 13;20(1):353. doi: 10.1186/s13063-019-3452-y.

2.

Benzylpenicillin versus flucloxacillin for penicillin susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study.

Henderson A, Harris P, Hartel G, Paterson D, Turnidge J, Davis JS, Tong SYC.

Int J Antimicrob Agents. 2019 Jun 7. pii: S0924-8579(19)30137-2. doi: 10.1016/j.ijantimicag.2019.05.020. [Epub ahead of print]

PMID:
31181352
3.

An urgent need for antimicrobial stewardship in Indigenous rural and remote primary health care.

Bowen AC, Daveson K, Anderson L, Tong SY.

Med J Aust. 2019 Jun 3. doi: 10.5694/mja2.50216. [Epub ahead of print] No abstract available.

PMID:
31155725
4.

Early transthoracic echocardiography has useful prognostic value in left-sided native valve endocarditis despite limited diagnostic performance.

Heriot GS, Newcomb A, Darby J, Wilson A, Tong SYC, Cheng AC, Liew D.

Eur J Clin Microbiol Infect Dis. 2019 May 28. doi: 10.1007/s10096-019-03589-w. [Epub ahead of print]

PMID:
31140069
5.

Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics.

Davies MR, McIntyre L, Mutreja A, Lacey JA, Lees JA, Towers RJ, Duchêne S, Smeesters PR, Frost HR, Price DJ, Holden MTG, David S, Giffard PM, Worthing KA, Seale AC, Berkley JA, Harris SR, Rivera-Hernandez T, Berking O, Cork AJ, Torres RSLA, Lithgow T, Strugnell RA, Bergmann R, Nitsche-Schmitz P, Chhatwal GS, Bentley SD, Fraser JD, Moreland NJ, Carapetis JR, Steer AC, Parkhill J, Saul A, Williamson DA, Currie BJ, Tong SYC, Dougan G, Walker MJ.

Nat Genet. 2019 Jun;51(6):1035-1043. doi: 10.1038/s41588-019-0417-8. Epub 2019 May 27.

PMID:
31133745
6.

Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study.

Ralph AP, Holt DC, Islam S, Osowicki J, Carroll DE, Tong SYC, Bowen AC.

Open Forum Infect Dis. 2019 Feb 26;6(4):ofz097. doi: 10.1093/ofid/ofz097. eCollection 2019 Apr.

7.

Mycobacterial mimicry in a man from Myanmar.

Griffin DW, Huang GKL, Lachapelle P, Tong SY, Mahanty S.

Med J Aust. 2019 May;210(8):349-351.e1. doi: 10.5694/mja2.50133. Epub 2019 Apr 9. No abstract available.

PMID:
30968416
8.

A survey of infectious diseases and microbiology clinicians in Australia and New Zealand about the management of Staphylococcus aureus bacteraemia.

Tong SYC, Campbell A, Bowen AC, Davis JS.

Clin Infect Dis. 2019 Apr 6. pii: ciz275. doi: 10.1093/cid/ciz275. [Epub ahead of print] No abstract available.

PMID:
30953050
9.

Systematic Review of Group A Streptococcal emm Types Associated with Acute Post-Streptococcal Glomerulonephritis.

Worthing KA, Lacey JA, Price DJ, McIntyre L, Steer AC, Tong SYC, Davies MR.

Am J Trop Med Hyg. 2019 May;100(5):1066-1070. doi: 10.4269/ajtmh.18-0827.

PMID:
30915958
10.

Burden of skin disease in two remote primary healthcare centres in northern and central Australia.

Thomas L, Bowen AC, Ly M, Connors C, Andrews R, Tong SYC.

Intern Med J. 2019 Mar;49(3):396-399. doi: 10.1111/imj.14222.

PMID:
30897665
11.

Tracing Ancient Human Migrations into Sahul Using Hepatitis B Virus Genomes.

Yuen LKW, Littlejohn M, Duchêne S, Edwards R, Bukulatjpi S, Binks P, Jackson K, Davies J, Davis JS, Tong SYC, Locarnini S.

Mol Biol Evol. 2019 May 1;36(5):942-954. doi: 10.1093/molbev/msz021.

PMID:
30856252
12.

The epidemiology of Staphylococcus aureus skin and soft tissue infection in the southern Barkly region of Australia's Northern Territory in 2017.

Davey RX, Tong SYC.

Pathology. 2019 Apr;51(3):308-312. doi: 10.1016/j.pathol.2018.11.010. Epub 2019 Feb 25.

PMID:
30819539
13.

Incidence of community onset MRSA in Australia: least reported where it is Most prevalent.

Cameron JK, Hall L, Tong SYC, Paterson DL, Halton K.

Antimicrob Resist Infect Control. 2019 Feb 12;8:33. doi: 10.1186/s13756-019-0485-7. eCollection 2019.

14.

High burden of infectious disease and antibiotic use in early life in Australian Aboriginal communities.

Cuningham W, McVernon J, Lydeamore MJ, Andrews RM, Carapetis J, Kearns T, Clucas D, Dhurrkay RG, Tong SYC, Campbell PT.

Aust N Z J Public Health. 2019 Apr;43(2):149-155. doi: 10.1111/1753-6405.12876. Epub 2019 Feb 6.

PMID:
30727032
15.

In Vitro and In Vivo Analysis of the Effects of 3,5-DMA and Its Metabolites in Neural Oxidative Stress and Neurodevelopmental Toxicity.

Chao MW, Kuo HC, Tong SY, Yang YS, Chuang YC, Tseng CY.

Toxicol Sci. 2019 Apr 1;168(2):405-419. doi: 10.1093/toxsci/kfy306.

PMID:
30590852
16.

Treatment, prevention and public health management of impetigo, scabies, crusted scabies and fungal skin infections in endemic populations: a systematic review.

May PJ, Tong SYC, Steer AC, Currie BJ, Andrews RM, Carapetis JR, Bowen AC.

Trop Med Int Health. 2019 Mar;24(3):280-293. doi: 10.1111/tmi.13198. Epub 2019 Jan 28. Review.

PMID:
30582783
17.

Benefit of Echocardiography in Patients With Staphylococcus aureus Bacteremia at Low Risk of Endocarditis.

Heriot GS, Tong SYC, Cheng AC, Liew D.

Open Forum Infect Dis. 2018 Dec 11;5(12):ofy303. doi: 10.1093/ofid/ofy303. eCollection 2018 Dec.

18.

Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection.

Doernberg SB, Tran TTT, Tong SYC, Paul M, Yahav D, Davis JS, Leibovici L, Boucher HW, Corey GR, Cosgrove SE, Chambers HF, Fowler VG, Evans SR, Holland TL; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2018 Oct 12. doi: 10.1093/cid/ciy766. [Epub ahead of print]

PMID:
30321315
19.

Adjunctive protein synthesis inhibitor antibiotics for toxin suppression in Staphylococcus aureus infections: a systematic appraisal.

Campbell AJ, Dotel R, Blyth CC, Davis JS, Tong SYC, Bowen AC.

J Antimicrob Chemother. 2019 Jan 1;74(1):1-5. doi: 10.1093/jac/dky387.

PMID:
30307507
20.

A biological model of scabies infection dynamics and treatment informs mass drug administration strategies to increase the likelihood of elimination.

Lydeamore MJ, Campbell PT, Regan DG, Tong SYC, Andrews RM, Steer AC, Romani L, Kaldor JM, McVernon J, McCaw JM.

Math Biosci. 2019 Mar;309:163-173. doi: 10.1016/j.mbs.2018.08.007. Epub 2018 Aug 24.

PMID:
30149021
21.

Scabies and risk of skin sores in remote Australian Aboriginal communities: A self-controlled case series study.

Aung PTZ, Cuningham W, Hwang K, Andrews RM, Carapetis JR, Kearns T, Clucas D, McVernon J, Simpson JA, Tong SYC, Campbell PT.

PLoS Negl Trop Dis. 2018 Jul 25;12(7):e0006668. doi: 10.1371/journal.pntd.0006668. eCollection 2018 Jul.

22.

Global Scale Dissemination of ST93: A Divergent Staphylococcus aureus Epidemic Lineage That Has Recently Emerged From Remote Northern Australia.

van Hal SJ, Steinig EJ, Andersson P, Holden MTG, Harris SR, Nimmo GR, Williamson DA, Heffernan H, Ritchie SR, Kearns AM, Ellington MJ, Dickson E, de Lencastre H, Coombs GW, Bentley SD, Parkhill J, Holt DC, Giffard PM, Tong SYC.

Front Microbiol. 2018 Jul 9;9:1453. doi: 10.3389/fmicb.2018.01453. eCollection 2018.

23.

Gene exchange drives the ecological success of a multi-host bacterial pathogen.

Richardson EJ, Bacigalupe R, Harrison EM, Weinert LA, Lycett S, Vrieling M, Robb K, Hoskisson PA, Holden MTG, Feil EJ, Paterson GK, Tong SYC, Shittu A, van Wamel W, Aanensen DM, Parkhill J, Peacock SJ, Corander J, Holmes M, Fitzgerald JR.

Nat Ecol Evol. 2018 Sep;2(9):1468-1478. doi: 10.1038/s41559-018-0617-0. Epub 2018 Jul 23.

24.

Cross-link regulation of precursor N-cadherin and FGFR1 by GDNF increases U251MG cell viability.

Tang CX, Gu YX, Liu XF, Tong SY, Ayanlaja AA, Gao Y, Ji GQ, Xiong Y, Huang LY, Gao DS.

Oncol Rep. 2018 Jul;40(1):443-453. doi: 10.3892/or.2018.6405. Epub 2018 Apr 30.

PMID:
29750313
25.

Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.

Cheah BC, Davies J, Singh GR, Wood N, Jackson K, Littlejohn M, Davison B, McIntyre P, Locarnini S, Davis JS, Tong SYC.

Vaccine. 2018 Jun 7;36(24):3533-3540. doi: 10.1016/j.vaccine.2018.01.062. Epub 2018 May 4.

PMID:
29735323
26.

Calculation of the age of the first infection for skin sores and scabies in five remote communities in northern Australia.

Lydeamore MJ, Campbell PT, Cuningham W, Andrews RM, Kearns T, Clucas D, Gundjirryirr Dhurrkay R, Carapetis J, Tong SYC, McCaw JM, McVernon J.

Epidemiol Infect. 2018 Jul;146(9):1194-1201. doi: 10.1017/S0950268818001061. Epub 2018 May 8.

PMID:
29734959
27.

Investigation of trimethoprim/sulfamethoxazole resistance in an emerging sequence type 5 methicillin-resistant Staphylococcus aureus clone reveals discrepant resistance reporting.

Harris TM, Bowen AC, Holt DC, Sarovich DS, Stevens K, Currie BJ, Howden BP, Carapetis JR, Giffard PM, Tong SYC.

Clin Microbiol Infect. 2018 Sep;24(9):1027-1029. doi: 10.1016/j.cmi.2018.04.020. Epub 2018 May 1. No abstract available.

PMID:
29723570
28.

Streptococcus gallolyticus subsp. pasteurianus meningitis complicated by venous sinus thrombosis: A case report.

Wardle M, Mu A, Tong SYC.

Int J Infect Dis. 2018 Jun;71:30-32. doi: 10.1016/j.ijid.2018.04.005. Epub 2018 Apr 12.

29.

The unique aspects of chronic hepatitis B infection in Aboriginal and Torres Strait Islander people.

Davies J, Boutlis CS, Marshall CS, Tong SYC, Davis JS.

Intern Med J. 2018 Apr;48(4):484-485. doi: 10.1111/imj.13759. No abstract available.

PMID:
29623985
30.

Pt-like Hydrogen Evolution Electrocatalysis on PANI/CoP Hybrid Nanowires by Weakening the Shackles of Hydrogen Ions on the Surfaces of Catalysts.

Feng JX, Tong SY, Tong YX, Li GR.

J Am Chem Soc. 2018 Apr 18;140(15):5118-5126. doi: 10.1021/jacs.7b12968. Epub 2018 Apr 9.

PMID:
29609454
31.

What risk of endocarditis is low enough to justify the omission of transoesophageal echocardiography in Staphylococcus aureus bacteraemia? A narrative review.

Heriot GS, Tong SYC, Cheng AC, Liew D.

Clin Microbiol Infect. 2018 Dec;24(12):1251-1256. doi: 10.1016/j.cmi.2018.03.027. Epub 2018 Mar 23. Review.

PMID:
29581048
32.

Implications of asymptomatic carriers for infectious disease transmission and control.

Chisholm RH, Campbell PT, Wu Y, Tong SYC, McVernon J, Geard N.

R Soc Open Sci. 2018 Feb 14;5(2):172341. doi: 10.1098/rsos.172341. eCollection 2018 Feb.

33.

Immortal Time Bias in Assessing Evidence-Based Care Processes for Staphylococcus aureus Bacteremia.

Tong SYC, Cheng AC, Denholm JT.

JAMA Intern Med. 2018 Feb 1;178(2):295-296. doi: 10.1001/jamainternmed.2017.7947. No abstract available.

PMID:
29404611
34.

Clinical variation in the use of echocardiography in Staphylococcus aureus bacteraemia: a multi-centre cohort study.

Heriot GS, Tong SYC, Cheng AC, Thevarajan I, Levinson MR, Visvanathan K, Liew D.

Eur J Clin Microbiol Infect Dis. 2018 Mar;37(3):469-474. doi: 10.1007/s10096-018-3192-z. Epub 2018 Jan 22.

PMID:
29357050
35.

Criteria for Identifying Patients With Staphylococcus aureus Bacteremia Who Are at Low Risk of Endocarditis: A Systematic Review.

Heriot GS, Cronin K, Tong SYC, Cheng AC, Liew D.

Open Forum Infect Dis. 2017 Nov 24;4(4):ofx261. doi: 10.1093/ofid/ofx261. eCollection 2017 Fall. Review.

36.

Antimicrobial resistance in urine and skin isolates in Timor-Leste.

Marr I, Sarmento N, O'Brien M, Lee K, Gusmao C, de Castro G, Janson S, Tong SYC, Baird RW, Francis JR.

J Glob Antimicrob Resist. 2018 Jun;13:135-138. doi: 10.1016/j.jgar.2017.12.010. Epub 2017 Dec 23.

37.

Sulfamethoxazole-Trimethoprim (Cotrimoxazole) for Skin and Soft Tissue Infections Including Impetigo, Cellulitis, and Abscess.

Bowen AC, Carapetis JR, Currie BJ, Fowler V Jr, Chambers HF, Tong SYC.

Open Forum Infect Dis. 2017 Nov 2;4(4):ofx232. doi: 10.1093/ofid/ofx232. eCollection 2017 Fall. Review.

38.

Prolonged Detection of Japanese Encephalitis Virus in Urine and Whole Blood in a Returned Short-term Traveler.

Huang GKL, Tio SY, Caly L, Nicholson S, Thevarajan I, Papadakis G, Catton M, Tong SYC, Druce J.

Open Forum Infect Dis. 2017 Sep 27;4(4):ofx203. doi: 10.1093/ofid/ofx203. eCollection 2017 Fall.

39.

Indigenous Australian household structure: a simple data collection tool and implications for close contact transmission of communicable diseases.

Vino T, Singh GR, Davison B, Campbell PT, Lydeamore MJ, Robinson A, McVernon J, Tong SYC, Geard N.

PeerJ. 2017 Oct 26;5:e3958. doi: 10.7717/peerj.3958. eCollection 2017.

40.

Clinical predictors and prediction rules to estimate initial patient risk for infective endocarditis in Staphylococcus aureus bacteraemia: attention must be paid to the reference standard.

Heriot GS, Cheng AC, Tong SYC, Liew D.

Clin Microbiol Infect. 2018 Mar;24(3):314-316. doi: 10.1016/j.cmi.2017.09.021. Epub 2017 Oct 10. No abstract available.

41.

Genome-Wide Analysis of Genetic Risk Factors for Rheumatic Heart Disease in Aboriginal Australians Provides Support for Pathogenic Molecular Mimicry.

Gray LA, D'Antoine HA, Tong SYC, McKinnon M, Bessarab D, Brown N, Reményi B, Steer A, Syn G, Blackwell JM, Inouye M, Carapetis JR.

J Infect Dis. 2017 Dec 12;216(11):1460-1470. doi: 10.1093/infdis/jix497.

PMID:
29029143
42.

Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population.

Davies J, Li SQ, Tong SY, Baird RW, Beaman M, Higgins G, Cowie BC, Condon JR, Davis JS.

PLoS One. 2017 Sep 8;12(9):e0184082. doi: 10.1371/journal.pone.0184082. eCollection 2017.

43.

The prediction of a family group of two-dimensional node-line semimetals.

Jin YJ, Wang R, Zhao JZ, Du YP, Zheng CD, Gan LY, Liu JF, Xu H, Tong SY.

Nanoscale. 2017 Sep 14;9(35):13112-13118. doi: 10.1039/c7nr03520a.

PMID:
28849838
44.

Towards identification of immune and genetic correlates of severe influenza disease in Indigenous Australians.

Clemens EB, Grant EJ, Wang Z, Gras S, Tipping P, Rossjohn J, Miller A, Tong SYC, Kedzierska K.

Immunol Cell Biol. 2017 Aug;95(7):648. doi: 10.1038/icb.2017.47.

45.

Staphylococcus aureus Prostatic abscess: a clinical case report and a review of the literature.

Carroll DE, Marr I, Huang GKL, Holt DC, Tong SYC, Boutlis CS.

BMC Infect Dis. 2017 Jul 21;17(1):509. doi: 10.1186/s12879-017-2605-4. Review.

46.

Zhao et al. Reply.

Zhao JZ, Fan W, Verstraete MJ, Zanolli Z, Fan J, Yang XB, Xu H, Tong SY.

Phys Rev Lett. 2017 Jun 9;118(23):239602. doi: 10.1103/PhysRevLett.118.239602. Epub 2017 Jun 9. No abstract available.

47.

Contaminated fingers: a potential cause of Chlamydia trachomatis-positive urine specimens.

Giffard PM, Lilliebridge RA, Wilson J, Murray G, Phillips S, Tabrizi SN, Garland SM, Martin L, Singh G, Tong SYC, Holt DC, Andersson P.

Sex Transm Infect. 2018 Feb;94(1):32-36. doi: 10.1136/sextrans-2016-053081. Epub 2017 Jun 9.

48.

High burden of complicated skin and soft tissue infections in the Indigenous population of Central Australia due to dominant Panton Valentine leucocidin clones ST93-MRSA and CC121-MSSA.

Harch SAJ, MacMorran E, Tong SYC, Holt DC, Wilson J, Athan E, Hewagama S.

BMC Infect Dis. 2017 Jun 7;17(1):405. doi: 10.1186/s12879-017-2460-3.

49.

Whole genome sequencing to investigate a putative outbreak of the virulent community-associated methicillin-resistant Staphylococcus aureus ST93 clone in a remote Indigenous community.

Meumann EM, Andersson P, Yeaman F, Oldfield S, Lilliebridge R, Bentley SD, Krause V, Beaman M, Currie BJ, Holt DC, Giffard PM, Tong SYC.

Microb Genom. 2016 Dec 12;2(12):e000098. doi: 10.1099/mgen.0.000098. eCollection 2016 Dec.

50.

A double-blind randomized controlled trial of ibuprofen compared to placebo for uncomplicated cellulitis of the upper or lower limb.

Davis JS, Mackrow C, Binks P, Fletcher W, Dettwiller P, Marshall C, Day J, Pratt W, Tong SY.

Clin Microbiol Infect. 2017 Apr;23(4):242-246. doi: 10.1016/j.cmi.2017.02.036. Epub 2017 Mar 6.

Supplemental Content

Support Center